Research news

Professor Nicolas Voelcker from the Monash Institute of Pharmaceutical Sciences (MIPS) has received a Humboldt Research Award to the value of EUR 60,000 (approximately AUD $94,000).The award has been granted by Germany’s Alexander von Humboldt

A team of Australian drug researchers from Monash University, The University of Sydney and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of

An invention developed by a team of researchers from the Monash Institute of Pharmaceutical Sciences and The Walter and Eliza Hall Institute of Medical Research has been granted patent by The European Patent Office and The United States Patent and

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with The Baker Heart and Diabetes Institute, have discovered a potential therapeutic target which could reduce heart failure and may improve the quality of

A new study led by Monash University has - for the first time - investigated how age, frailty and dementia predict hospital discharge prescribing for people with Type 2 Diabetes (T2D), with the researchers finding that people aged 80+ are

The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running.

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to enhance the utility of

World first: Researchers from Monash University have harnessed cutting-edge technology to discover the progression of molecular events that lead to migraine – something that, until now, has remained a mystery.

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with researchers at the Surgical and Translational Research (STaR) Centre at the University of Auckland, have found that a common medication used to treat